Pediatric Hematology and Oncology

62 questions

Question 1Question →

A pediatric hematology and oncology team is reviewing diagnostic studies for several newly admitted children. Match each characteristic cytogenetic or molecular finding with its corresponding pediatric malignancy.

Click a left item, then click its matching right item

Items

t(8;14) translocation involving the c-MYC oncogene
t(12;21) translocation involving ETV6-RUNX1
Amplification of the N-MYC oncogene
t(15;17) translocation yielding the PML-RARA fusion protein

Matches

Show answer & explanation

Answer

t(8;14) matches Burkitt lymphoma; t(12;21) matches B-ALL; N-MYC amplification matches Neuroblastoma; t(15;17) matches Acute promyelocytic leukemia.
Each cytogenetic abnormality uniquely corresponds to a specific pediatric malignancy. Burkitt lymphoma is driven by c-MYC via t(8;14); childhood B-ALL frequently features t(12;21); neuroblastoma severity is linked to N-MYC amplification; and acute promyelocytic leukemia is defined by the t(15;17) PML-RARA fusion.

Step-by-Step Solution

1
Evaluate the t(8;14) translocation.
Identified as the c-MYC translocation associated with Burkitt lymphoma.
c-MYC over-expression drives the 'starry sky' appearance and rapid growth characteristic of Burkitt lymphoma.
2
Evaluate the t(12;21) translocation.
Identified as the ETV6-RUNX1 fusion associated with B-cell acute lymphoblastic leukemia.
This is a key prognostic marker in pediatric B-ALL, indicating a favorable outcome and specific leukemogenesis pathway.
3
Evaluate the amplification of N-MYC.
Identified as a hallmark of high-risk neuroblastoma.
Neuroblastoma often exhibits N-MYC amplification (visible as double minutes or homogeneously staining regions), which directly correlates with tumor aggressiveness.
4
Evaluate the t(15;17) translocation.
Identified as the PML-RARA fusion associated with acute promyelocytic leukemia.
This specific translocation blocks promyelocyte differentiation, leading to APL and its associated severe coagulopathy.

Key Concept

Cytogenetic and molecular markers are essential for diagnosing, risk-stratifying, and guiding the targeted treatment of pediatric hematologic and solid malignancies.
Question 2Question →

A 4-year-old girl is brought to the clinic by her parents due to a two-week history of worsening fatigue, spontaneous bruising on her legs, and intermittent low-grade fevers. Physical examination reveals generalized lymphadenopathy and mild hepatosplenomegaly. The physician suspects acute lymphoblastic leukemia (ALL). Arrange the following diagnostic steps in the most appropriate chronological order, from initial screening to definitive staging.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: Complete blood count with differential -> Peripheral blood smear review -> Bone marrow aspiration and biopsy -> Lumbar puncture.
The standard diagnostic pathway for pediatric leukemia begins with the least invasive screening (complete blood count), follows with morphological evaluation of the blood (peripheral smear), proceeds to definitive diagnosis (bone marrow aspiration), and concludes with staging for extramedullary disease (lumbar puncture).

Step-by-Step Solution

1
Order initial laboratory screening.
A complete blood count with differential is obtained.
It is the least invasive, fastest initial test to identify marrow failure or abnormal white cell lines.
2
Evaluate cellular morphology.
A peripheral blood smear is reviewed.
It provides direct visual evidence of circulating blast cells, guiding the decision for invasive bone marrow testing.
3
Confirm the suspected diagnosis.
A bone marrow aspiration and biopsy are performed.
A definitive diagnosis of acute leukemia requires tissue confirmation showing an elevated blast percentage in the bone marrow.
4
Stage the disease for central nervous system involvement.
A lumbar puncture is performed.
Staging dictates the specific intensity of systemic and intrathecal therapy protocols.

Key Concept

The diagnostic workup for pediatric acute lymphoblastic leukemia proceeds stepwise from basic non-invasive blood tests to definitive marrow evaluation, culminating in staging procedures.
Question 3Question →

A crucial component of pediatric hematology and oncology is managing the long-term survivorship of patients exposed to cytotoxic chemotherapy. Match the following chemotherapeutic classes commonly used in pediatric malignancies to their precise mechanism of target-organ toxicity or associated secondary malignancy.

Click a left item, then click its matching right item

Items

Anthracyclines (e.g., Doxorubicin)
Platinum compounds (e.g., Cisplatin)
Nitrogen mustards (e.g., Cyclophosphamide)
Epipodophyllotoxins (e.g., Etoposide)

Matches

Show answer & explanation

Answer

Anthracyclines match with reactive oxygen species and topoisomerase II β\beta (cardiomyopathy). Platinum compounds match with apoptosis of outer hair cells (sensorineural hearing loss). Nitrogen mustards match with acrolein production (hemorrhagic cystitis). Epipodophyllotoxins match with DNA double-strand breaks and 11q23 translocations (secondary AML).
Each chemotherapeutic agent causes distinct cellular damage leading to specific late effects. Anthracyclines bind topoisomerase II β\beta and create ROS in myocytes (cardiomyopathy). Cisplatin damages outer hair cells (ototoxicity). Cyclophosphamide yields acrolein (hemorrhagic cystitis). Etoposide causes DNA breaks leading to KMT2A translocations (secondary AML).

Step-by-Step Solution

1
Evaluate the mechanism of toxicity for Anthracyclines (Doxorubicin).
Matched to the generation of reactive oxygen species and interaction with topoisomerase II β\beta.
This is the classic mechanism by which anthracyclines cause cumulative, irreversible dilated cardiomyopathy, a major focus in pediatric cancer survivorship.
2
Evaluate the mechanism of toxicity for Platinum compounds (Cisplatin).
Matched to the apoptosis of outer hair cells in the basal turn of the cochlea.
Cisplatin causes irreversible, bilateral sensorineural hearing loss by damaging the organ of Corti. It also causes nephrotoxicity, but the precise cochlear mechanism is defining.
3
Evaluate the mechanism of toxicity for Nitrogen mustards (Cyclophosphamide).
Matched to the production of the toxic urothelial metabolite acrolein.
Cyclophosphamide causes hemorrhagic cystitis via its metabolite acrolein; this toxicity is specifically prevented by administering mesna, which binds and detoxifies acrolein in the bladder.
4
Evaluate the mechanism of toxicity for Epipodophyllotoxins (Etoposide).
Matched to DNA double-strand breaks increasing the risk of secondary AML with 11q23 translocations.
Etoposide is strongly associated with therapy-related malignancies, classically a secondary acute myeloid leukemia (t-AML) featuring KMT2A (MLL) translocations, usually presenting 1-3 years post-therapy.

Key Concept

Pathophysiologic mechanisms of late effects and toxicities from pediatric chemotherapy
Estimated Time:1m 30s
Question 4Question →

A seven-year-old girl with a history of retroperitoneal neuroblastoma is brought to the emergency department due to severe, worsening mid-back pain for the past three days and new-onset difficulty walking over the last twelve hours. Her parents report she has not voided urine since yesterday evening. Vital signs are within normal limits for her age. Neurologic examination reveals grade three out of five motor strength in the bilateral lower extremities, hyperreflexia at the patellae, and decreased sensation to light touch below the umbilicus. The bladder is palpably distended. Arrange the following management steps in the most appropriate chronological sequence for this patient's suspected complication.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence of management is to first administer intravenous high-dose corticosteroids, followed by obtaining an urgent MRI of the entire spine, and finally proceeding with definitive neurosurgical decompression or radiation therapy.
Malignant spinal cord compression is an oncologic emergency characterized by back pain, motor weakness, sensory deficits, and autonomic dysfunction (e.g., urinary retention). In a pediatric patient with a known solid tumor such as neuroblastoma, these symptoms are highly suspicious for epidural metastasis or direct tumor extension into the spinal canal. The most critical initial step is the immediate administration of high-dose intravenous corticosteroids (such as dexamethasone) to decrease vasogenic edema and alleviate pressure on the spinal cord. This must be done promptly upon clinical suspicion to preserve neurologic function. Following initial pharmacologic stabilization, an urgent MRI of the entire spine is indicated to accurately visualize the level and extent of the compression. Once the precise anatomy is defined by the MRI, definitive therapy involving surgical decompression (e.g., laminectomy) or emergent radiation therapy is performed.

Step-by-Step Solution

1
Identify the oncologic emergency based on the clinical presentation.
The patient is presenting with signs of malignant spinal cord compression (back pain, lower extremity weakness, sensory level, urinary retention) in the setting of a known solid tumor (neuroblastoma).
Recognizing the constellation of upper motor neuron signs and autonomic dysfunction localized to the spinal cord is crucial for prioritizing immediate interventions.
2
Determine the most urgent medical intervention for suspected cord compression.
Select intravenous high-dose corticosteroids as the immediate first step.
Corticosteroids rapidly reduce peritumoral vasogenic edema, providing immediate relief of pressure on the spinal cord and preventing permanent ischemic injury while awaiting imaging.
3
Select the appropriate diagnostic imaging modality.
Select urgent MRI of the entire spine as the subsequent step.
MRI is required to confirm the diagnosis and provide a detailed anatomic map for surgical or radiation oncologists.
4
Determine the definitive treatment step.
Select neurosurgical decompression or radiation therapy as the final step in the sequence.
Once the anatomy is confirmed, physical removal of the tumor or targeted radiation provides definitive local control and durable decompression of the spinal cord.

Key Concept

Management Sequence for Malignant Spinal Cord Compression
Question 5Question →

A 66-year-old boy with sickle cell disease (HbSS) is brought to the emergency department due to increasing fatigue and generalized weakness over the past 4848 hours. One week ago, he had a low-grade fever accompanied by a bright red "slapped-cheek" facial rash that has since faded. He reports no pain in his chest, abdomen, or extremities. His temperature is 37.1∘C37.1^\circ\text{C} (98.8∘F98.8^\circ\text{F}), blood pressure is 95/60 mm Hg95/60 \text{ mm Hg}, pulse is 135/min135/\text{min}, and respirations are 22/min22/\text{min}. Physical examination reveals marked conjunctival pallor and a grade 2/62/6 systolic flow murmur at the left upper sternal border. The abdomen is soft and non-tender, and the spleen is not palpable. Laboratory studies show:

Laboratory TestResult
Hemoglobin3.9 g/dL3.9 \text{ g/dL} (baseline 7.5 g/dL7.5 \text{ g/dL})
Mean corpuscular volume86 fL86 \text{ fL}
Platelets310,000/mm3310,000/\text{mm}^3
Leukocytes8,500/mm38,500/\text{mm}^3
Reticulocytes0.1%0.1\% (baseline 8%−10%8\%-10\%)

Which of the following is the most likely underlying mechanism for this patient's acute hematologic presentation?

Show answer & explanation

Answer: Transient arrest of erythropoiesis by a viral pathogen

Answer

The correct answer is the transient arrest of erythropoiesis by a viral pathogen, which describes an aplastic crisis triggered by Parvovirus B19.
The correct answer accurately describes the pathophysiology of an aplastic crisis. Parvovirus B19 (the cause of Erythema infectiosum or 'Fifth disease', marked by a 'slapped-cheek' rash) has a strong tropism for erythroid progenitor cells in the bone marrow. In healthy individuals, the resulting transient halt in erythropoiesis goes largely unnoticed. However, in patients with sickle cell disease whose red blood cells have a drastically shortened lifespan (e.g., 1010-2020 days), this temporary arrest leads to a precipitous drop in hemoglobin. The hallmark laboratory finding is a profoundly low reticulocyte count in the setting of severe anemia.

Step-by-Step Solution

1
Analyze the patient's symptoms and vital signs.
A 66-year-old boy with sickle cell disease presents with severe, symptomatic anemia (tachycardia, flow murmur, fatigue) without any pain or splenomegaly.
To establish the primary clinical problem, which is an acute decompensation of his chronic baseline anemia.
2
Evaluate the laboratory findings, paying special attention to the reticulocyte count.
The hemoglobin has dropped severely to 3.9 g/dL3.9 \text{ g/dL}, and the reticulocyte count is 0.1%0.1\%, which is inappropriately low for a patient with chronic hemolytic anemia.
To differentiate between hyperproliferative causes of acute anemia (e.g., splenic sequestration, hyperhemolysis) and hypoproliferative causes (e.g., aplastic crisis).
3
Correlate the hematologic findings with the patient's recent infectious history.
The patient recently had a 'slapped-cheek' rash, which is pathognomonic for Erythema infectiosum caused by Parvovirus B19.
To definitively identify the etiology. Parvovirus B19 specifically infects erythroid progenitor cells, causing a temporary halt in red blood cell production that is life-threatening in patients with shortened RBC lifespans.

Key Concept

An aplastic crisis in sickle cell disease is typically triggered by Parvovirus B19 infection, which specifically targets erythroid progenitor cells and halts red blood cell production, presenting as severe acute anemia with a dangerously low reticulocyte count.
Question 6Question →

A 44-year-old boy is evaluated in the pediatric oncology clinic for an urgent follow-up. He was diagnosed with standard-risk B-cell acute lymphoblastic leukemia (ALL) eight months ago and is currently in the maintenance phase of chemotherapy. Today, he has mild rhinorrhea but is otherwise active and playful. His mother reports that the patient spent the weekend with his 66-year-old cousin. Three days after the exposure, the cousin developed a low-grade fever and a diffuse vesicular rash that was subsequently diagnosed as chickenpox by a pediatrician. The patient has never had chickenpox and missed his routine preschool immunizations due to his cancer diagnosis. The patient's temperature is 37.1∘C37.1^\circ\text{C} (98.8∘F98.8^\circ\text{F}), blood pressure is 95/60 mmHg95/60 \text{ mmHg}, heart rate is 100/min100/\text{min}, and respiratory rate is 20/min20/\text{min}. Physical examination reveals clear lungs, normal heart sounds, and no skin lesions. Laboratory studies show a leukocyte count of 3,200/mm33,200/\text{mm}^3 with an absolute neutrophil count of 1,600/mm31,600/\text{mm}^3. The mother asks how to protect her son from the exposure. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Administer varicella-zoster immune globulin

Answer

Administer varicella-zoster immune globulin to provide passive immunity, as the patient is immunocompromised and cannot safely receive the live vaccine.
The patient is susceptible to varicella and is severely immunocompromised due to ongoing maintenance chemotherapy for acute lymphoblastic leukemia (ALL). Varicella infection in this population can lead to severe complications, including pneumonia, encephalitis, and multiorgan failure. Because he is immunocompromised, the standard post-exposure prophylaxis with the live-attenuated varicella vaccine is strictly contraindicated. Instead, he requires passive immunization with varicella-zoster immune globulin (VZIG), ideally administered within 96 hours (up to 10 days) of exposure, to prevent or attenuate the disease.

Step-by-Step Solution

1
Assess the patient's immune status and susceptibility.
The patient is on active maintenance chemotherapy for ALL, making him significantly immunocompromised. He is susceptible because he has not had the disease or the vaccine.
Determines the safety profile of interventions (e.g., live vaccines are contraindicated in severe immunosuppression).
2
Evaluate the clinical event.
The patient had a significant exposure to varicella-zoster virus (spending the weekend with a contagious cousin).
Significant exposure in a susceptible, high-risk host requires immediate post-exposure prophylaxis.
3
Select the appropriate prophylactic agent.
Varicella-zoster immune globulin (VZIG) is selected over the active varicella vaccine.
Since active immunization with a live-attenuated virus could cause severe disease in this immunocompromised child, passive immunization with pre-formed antibodies (VZIG) is the standard of care.

Key Concept

Management of viral exposures and vaccine contraindications in pediatric oncology patients.
Estimated Time:1m 15s
Question 7Question →

A 6-year-old boy is newly diagnosed with Burkitt lymphoma. He presents with a large abdominal mass, and laboratory studies reveal a significantly elevated serum lactate dehydrogenase (LDH) and uric acid level. The oncology team is preparing to begin his treatment but must first address his high risk for developing tumor lysis syndrome (TLS). Arrange the following management steps in the most appropriate sequential order, starting from the most critical initial preventive measure to the intervention reserved for severe, refractory complications.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is to first initiate aggressive intravenous hydration, followed by administering a hypouricemic agent, then administering cytotoxic chemotherapy, and finally initiating renal replacement therapy only if severe refractory complications arise.
Tumor lysis syndrome (TLS) is an oncologic emergency caused by the massive release of intracellular contents (potassium, phosphate, and nucleic acids) into the systemic circulation following tumor cell death. In high-risk pediatric patients, such as those with Burkitt lymphoma, prevention is paramount and must follow a specific sequence. The most critical initial step is aggressive intravenous hydration (without potassium) to maintain high urine output and clear metabolites. This is followed by administering a hypouricemic agent (such as rasburicase or allopurinol) to lower uric acid levels. Only after these preventive measures are actively working should cytotoxic chemotherapy be initiated, as it will trigger further rapid cell death. Finally, renal replacement therapy (hemodialysis) is not a preventive measure but a rescue therapy reserved as a last resort for severe complications, such as refractory hyperkalemia or acute renal failure, that do not respond to medical management.

Step-by-Step Solution

1
Identify the patient's risk profile for tumor lysis syndrome (TLS).
The patient has Burkitt lymphoma with a large tumor burden and elevated LDH, indicating a very high risk for TLS.
Risk stratification determines the necessity and intensity of prophylactic measures before starting oncologic treatment.
2
Establish the correct sequence of preventive measures prior to cellular breakdown.
Intravenous hydration and hypouricemic agents (like rasburicase) must be administered first.
These interventions optimize renal clearance and actively lower circulating uric acid levels before chemotherapy induces massive cell lysis.
3
Determine the appropriate timing for chemotherapy and rescue therapies.
Chemotherapy follows prophylaxis; hemodialysis is reserved for refractory cases.
Chemotherapy triggers the lysis and should not be given until the kidneys are protected. Dialysis is only indicated if prophylaxis fails and life-threatening metabolic derangements (e.g., hyperkalemia) occur.

Key Concept

Prevention and management sequence for Tumor Lysis Syndrome in high-risk pediatric malignancies
Question 8Question →

A 9-year-old boy is hospitalized for the management of acute myeloid leukemia. He recently completed his first cycle of induction chemotherapy. Five days ago, he developed a fever of 39.4∘C39.4^\circ C (102.9∘F102.9^\circ F) and was found to have an absolute neutrophil count (ANC) of 120/μL120/\mu L. Blood and urine cultures were drawn, and empiric intravenous cefepime was initiated.

Today (hospital day 6 of fever), his temperature remains elevated at 39.2∘C39.2^\circ C (102.6∘F102.6^\circ F). His blood pressure is 105/65 mmHg, and heart rate is 110/min. Physical examination reveals a clean central venous catheter site with no surrounding erythema or tenderness. The lungs are clear to auscultation, and there are no oral lesions or skin rashes.

Laboratory studies today show:

TestResult
Hemoglobin8.5 g/dL8.5\text{ g/dL}
Leukocytes300/μL300/\mu L
Absolute neutrophil count80/μL80/\mu L
Platelets45,000/μL45,000/\mu L

Blood cultures from admission and from two days ago have shown no growth. A chest radiograph reveals no infiltrates. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Add intravenous caspofungin

Answer

The correct answer is adding an empiric intravenous antifungal agent such as caspofungin.
The correct answer is adding an empiric antifungal agent such as caspofungin. This patient has high-risk, profound, and prolonged febrile neutropenia. When fever lasts longer than 4 to 7 days despite appropriate broad-spectrum antibacterial therapy, patients are at a significantly increased risk for invasive fungal infections, most commonly from Candida and Aspergillus species. Because these infections are difficult to culture early and carry high mortality, guidelines mandate the addition of an empiric systemic antifungal agent (such as an echinocandin, liposomal amphotericin B, or voriconazole) while continuing the existing antibacterial regimen.

Step-by-Step Solution

1
Evaluate the clinical scenario and the timeline of the patient's symptoms.
The patient is a child with acute myeloid leukemia experiencing persistent febrile neutropenia on hospital day 6, despite receiving appropriate initial broad-spectrum antibacterial therapy with cefepime.
Establishing the duration of febrile neutropenia (4-7 days) is the critical branch point in fever management protocols for neutropenic patients.
2
Assess the patient for localizing signs of bacterial infection or clinical deterioration.
The patient is hemodynamically stable, has a clean central line site, no oral lesions, clear lungs, and negative serial blood cultures.
This rules out the immediate need for Gram-positive coverage (like vancomycin) or escalation of antibacterial therapy (like meropenem).
3
Determine the guideline-based next step for unresolved neutropenic fever.
Guidelines dictate that for fever persisting 4 to 7 days without an identified bacterial source in a profoundly neutropenic patient, empiric systemic antifungal therapy must be added.
These patients are at an exceptionally high risk for invasive fungal infections (e.g., Candida, Aspergillus), which can be rapidly fatal and are notoriously difficult to diagnose early with standard cultures.

Key Concept

In patients with high-risk, prolonged febrile neutropenia (persisting 4-7 days despite broad-spectrum antibacterial therapy), empiric systemic antifungal therapy must be added due to the high risk of invasive fungal infections.
Question 9Question →

A 99-year-old boy with a known history of sickle cell anemia (HbSS) is brought to the emergency department by his parents. 11 hour ago, he suddenly developed slurred speech and weakness in his right arm and leg. On presentation, his temperature is 37.1∘C37.1^\circ\text{C} (98.8∘F98.8^\circ\text{F}), blood pressure is 110/70 mmHg110/70\text{ mmHg}, heart rate is 105/min105/\text{min}, and respiratory rate is 18/min18/\text{min}. Physical examination reveals an alert child with a right-sided facial droop and dense right-sided hemiparesis. Arrange the following management steps in the most appropriate chronological sequence for this patient.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: initial stabilization, followed by a non-contrast head CT, then an emergent exchange transfusion, and finally the initiation of a chronic monthly transfusion program.
The patient is experiencing an acute ischemic stroke, a severe neurological emergency associated with sickle cell disease. The immediate priority is to ensure the airway is patent and hemodynamics are stable. Once the ABCs are secured, a non-contrast CT of the head is the fastest and most appropriate test to exclude an intracranial hemorrhage. After hemorrhage is ruled out, the definitive treatment is an emergent exchange blood transfusion. This procedure physically removes the sickled red blood cells and replaces them with healthy red blood cells, rapidly decreasing the proportion of hemoglobin S to less than 30%30\% without causing hyperviscosity. Finally, because the risk of recurrent stroke is extremely high in these patients without secondary prophylaxis, they must be placed on a chronic monthly transfusion program to continually suppress endogenous sickled red blood cell production.

Step-by-Step Solution

1
Recognize the clinical presentation of an acute ischemic stroke in a patient with sickle cell disease.
The acute onset of focal neurologic deficits (slurred speech, hemiparesis) in a child with HbSS strongly suggests an acute stroke.
Sickle cell disease causes sickling of red blood cells leading to vaso-occlusion, and the cerebral vasculature is a common site, leading to ischemic infarction.
2
Prioritize initial emergency management steps.
The first step is stabilization (ABCs), followed immediately by ruling out hemorrhage using a non-contrast head CT.
Stabilization ensures survival, and a head CT dictates whether the stroke is ischemic or hemorrhagic, which critically alters subsequent management.
3
Determine the definitive acute and long-term therapies.
For an ischemic stroke, emergent exchange transfusion is required acutely, followed by chronic transfusions long-term.
Exchange transfusion rapidly removes sickled cells and replaces them with normal RBCs to lower HbS to less than 30%30\%, while chronic transfusions prevent recurrence.

Key Concept

The acute management of ischemic stroke in sickle cell disease requires emergent exchange blood transfusion to rapidly lower Hemoglobin S levels, followed by long-term chronic transfusion therapy to prevent recurrence.
Question 10Question →

A 7-year-old boy with newly diagnosed Burkitt lymphoma is started on induction chemotherapy. Within 24 hours, he develops lethargy, nausea, and decreased urine output. Laboratory studies show hyperkalemia, hyperphosphatemia, hypocalcemia, and elevated serum uric acid levels. Arrange the following pathophysiologic events in the correct chronological order leading to this patient's acute kidney injury.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

Rapid lysis of neoplastic cells -> Massive release of intracellular contents -> Metabolism of nucleic acids into uric acid -> Precipitation of crystals in renal tubules -> Intratubular obstruction and acute kidney injury.
Tumor lysis syndrome (TLS) is an oncologic emergency characterized by the massive destruction of tumor cells, most commonly seen after initiating chemotherapy for high-grade hematologic malignancies like Burkitt lymphoma or acute lymphoblastic leukemia. The correct sequence of pathogenesis begins with the lysis of these neoplastic cells. This lysis causes a massive release of intracellular contents into the systemic circulation, specifically potassium, phosphorus, and nucleic acids. The purine nucleic acids are subsequently transported to the liver, where xanthine oxidase metabolizes them into uric acid, resulting in hyperuricemia. The high concentration of uric acid can precipitate in the acidic environment of the renal tubules. Additionally, the excess phosphate binds to circulating calcium, causing hypocalcemia and forming calcium phosphate crystals, which also precipitate in the kidneys. Ultimately, these crystals cause physical intratubular obstruction, leading to oliguria and acute kidney injury.

Step-by-Step Solution

1
Identify the clinical syndrome presented in the vignette.
The patient has Tumor Lysis Syndrome (TLS) following chemotherapy for Burkitt lymphoma.
Burkitt lymphoma is a highly proliferative tumor, and the patient presents with the classic metabolic triad of TLS: hyperkalemia, hyperphosphatemia, and hyperuricemia (which causes secondary hypocalcemia).
2
Trace the origin of the metabolic abnormalities.
Chemotherapy causes cell lysis, releasing intracellular ions (potassium, phosphate) and purine nucleic acids into the extracellular space.
Malignant cells have high intracellular concentrations of these substances compared to extracellular fluid.
3
Determine the mechanism of acute kidney injury in this syndrome.
Purines are metabolized to uric acid, which precipitates in the kidneys along with calcium phosphate, causing mechanical obstruction.
Uric acid is poorly soluble in acidic urine, and calcium phosphate precipitates when the calcium-phosphorus product is elevated, leading to acute tubular injury.

Key Concept

Pathophysiology of Tumor Lysis Syndrome
Estimated Time:1m 0s
Question 11Question →

A 2-year-old boy with sickle cell disease (HbSS) is brought to the emergency department by his parents due to the sudden onset of severe lethargy, pallor, and abdominal swelling. His parents report that he was playing normally this morning but became progressively weak and poorly responsive over the past 3 hours. His temperature is 37.1°C (98.8°F), heart rate is 165/min, respiratory rate is 40/min, and blood pressure is 75/40 mm Hg. Physical examination reveals marked conjunctival pallor and a massively enlarged, firm spleen extending into the left lower quadrant. Laboratory studies show a hemoglobin of 3.8 g/dL, platelets of 80,000/mm³, and a reticulocyte count of 18%. What is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Rapid administration of isotonic intravenous fluids and a packed red blood cell transfusion

Answer

Rapid administration of isotonic intravenous fluids and a packed red blood cell transfusion
The correct answer is rapid administration of isotonic intravenous fluids and a packed red blood cell transfusion. This patient's presentation of sudden-onset severe anemia, hypovolemic shock (tachycardia, hypotension), an elevated reticulocyte count, and a rapidly enlarging spleen is classic for acute splenic sequestration crisis, a life-threatening complication of sickle cell disease. Immediate volume resuscitation and blood transfusion are required to restore intravascular volume and oxygen-carrying capacity.

Step-by-Step Solution

1
Identify the patient's underlying condition and presenting symptoms.
The patient has sickle cell disease and presents with hypovolemic shock (tachycardia, hypotension), severe anemia, elevated reticulocyte count, and a rapidly enlarging spleen.
Recognizing this classic triad establishes the diagnosis of acute splenic sequestration crisis.
2
Determine the most appropriate immediate management.
Immediate volume resuscitation with isotonic fluids and a packed red blood cell transfusion is required.
The condition involves massive pooling of blood in the spleen, leading to life-threatening intravascular volume depletion that must be rapidly corrected to prevent cardiovascular collapse.

Key Concept

Acute splenic sequestration crisis is a life-threatening complication in young children with sickle cell disease characterized by severe anemia, rapidly enlarging splenomegaly, and hypovolemic shock, requiring immediate fluid resuscitation and blood transfusion.
Estimated Time:1m 0s
Question 12Question →

Match each characteristic peripheral blood smear or microscopic finding with the most likely corresponding pediatric hematologic or oncologic diagnosis.

Click a left item, then click its matching right item

Items

Basophilic stippling
Bite cells and Heinz bodies
Howell-Jolly bodies
Small, round erythrocytes lacking central pallor
Myeloblasts with rod-shaped intracytoplasmic inclusions (Auer rods)

Matches

Show answer & explanation

Answer

The correct pairings link specific morphological anomalies to their pathophysiology: Basophilic stippling matches with lead toxicity, bite cells/Heinz bodies match with G6PD deficiency, Howell-Jolly bodies match with sickle cell disease asplenia, spherocytes match with hereditary spherocytosis, and Auer rods match with acute myeloid leukemia.
Each morphological finding directly reflects the underlying cellular pathology of the disease. Inhibited rRNA breakdown causes basophilic stippling in lead poisoning. Unchecked oxidative stress denatures hemoglobin in G6PD deficiency. Failure of the spleen to cull nuclear remnants leaves Howell-Jolly bodies in sickle cell disease. Cytoskeletal uncoupling forces RBCs into a spherical shape in hereditary spherocytosis. Finally, malignant clonal expansion of myeloid precursors produces myeloblasts with fused primary granules (Auer rods) in AML.

Step-by-Step Solution

1
Evaluate the finding of basophilic stippling.
Matches with lead toxicity.
Lead toxicity inhibits ribosomal RNA degradation, causing visible ribosomal aggregates.
2
Evaluate the finding of bite cells and Heinz bodies.
Matches with Glucose-6-phosphate dehydrogenase deficiency.
Deficient antioxidant capacity leads to denatured hemoglobin (Heinz bodies) which are partially phagocytosed by splenic macrophages (bite cells).
3
Evaluate the finding of Howell-Jolly bodies.
Matches with Sickle cell disease (post-autosplenectomy).
These are retained nuclear remnants that normally require a functional spleen for removal. Patients with sickle cell disease undergo autosplenectomy during early childhood.
4
Evaluate the finding of small, round erythrocytes lacking central pallor.
Matches with Hereditary spherocytosis.
Cytoskeletal defects lead to membrane blebbing and loss of surface area, resulting in the spherical red blood cells without central pallor.
5
Evaluate the finding of myeloblasts with rod-shaped intracytoplasmic inclusions.
Matches with Acute myeloid leukemia.
Auer rods are fused primary granules pathognomonic for myeloblasts, distinguishing AML from ALL.

Key Concept

Characteristic peripheral blood smear morphologies provide essential, high-yield diagnostic clues for differentiating common pediatric hematologic and oncologic conditions.
Question 13Question →

A 4-year-old boy is brought to the pediatrician's office by his parents after they noticed a red, pinpoint rash on his legs and arms this morning. The patient had a mild upper respiratory tract infection two weeks ago but has completely recovered. He is currently active and well-appearing. His temperature is 37.0°C (98.6°F), blood pressure is 95/60 mmHg, pulse is 90/min, and respirations are 20/min. Physical examination reveals scattered petechiae and purpura over the lower extremities. There is no hepatosplenomegaly, lymphadenopathy, or joint swelling. Laboratory evaluation shows:

Hemoglobin: 12.2 g/dL
Leukocyte count: 7,500/mm³
Platelet count: 15,000/mm³
Prothrombin time: 11 seconds (normal: 11-15 seconds)
Activated partial thromboplastin time: 30 seconds (normal: 25-40 seconds)

Which of the following is the most likely diagnosis?

Show answer & explanation

Answer: Immune thrombocytopenia

Answer

Immune thrombocytopenia
The correct diagnosis is Immune thrombocytopenia (ITP). ITP is an acquired autoimmune disorder characterized by isolated thrombocytopenia (platelet count < 100,000/mm³). In children, it most commonly presents at ages 2-5 years, typically occurring 1-4 weeks after a viral infection. The patient develops a sudden onset of petechiae, purpura, and mucosal bleeding but remains otherwise asymptomatic and well-appearing. Physical examination is notable for the absence of hepatosplenomegaly or lymphadenopathy, which helps differentiate ITP from malignancies like leukemia. The diagnostic hallmark is isolated thrombocytopenia with a normal white blood cell count, normal hemoglobin level, and normal coagulation profile (PT and aPTT).

Step-by-Step Solution

1
Analyze the patient's clinical presentation.
A well-appearing 4-year-old child presents with petechiae and purpura following a recent viral upper respiratory infection. He has no hepatosplenomegaly or lymphadenopathy.
Identifying the clinical stability and physical exam findings helps rule out severe systemic illnesses or malignancies.
2
Interpret the laboratory findings.
The patient has isolated thrombocytopenia (platelets 15,000/mm³) with normal hemoglobin, leukocyte count, and coagulation studies (PT and aPTT).
Normal hemoglobin and leukocyte counts point away from bone marrow failure or leukemia. Normal coagulation studies rule out factor deficiencies and DIC.
3
Synthesize findings to determine the diagnosis.
Isolated thrombocytopenia in a well-appearing child after a viral illness is the classic presentation of immune thrombocytopenia.
Antibodies to platelet surface antigens often form after viral infections, leading to platelet destruction in the spleen.

Key Concept

Immune thrombocytopenia (ITP) in children typically presents with sudden onset of petechiae and purpura in an otherwise healthy, well-appearing child, often following a viral infection. Laboratory testing reveals isolated thrombocytopenia.
Question 14Question →

A 14-year-old boy is evaluated in the emergency department for a 3-day history of progressively worsening headache, blurred vision, and shortness of breath. Physical examination reveals pale conjunctivae, scattered petechiae, and bilateral retinal hemorrhages. Vital signs are temperature 37.8°C (100.0°F), heart rate 132/min, respiratory rate 28/min, and blood pressure 110/65 mmHg. Pulse oximetry shows 92% on room air.

Laboratory studies show:
Leukocytes: 380,000/mm³ (90% myeloblasts)
Hemoglobin: 5.2 g/dL
Platelets: 22,000/mm³
Uric acid: 9.8 mg/dL
Potassium: 4.8 mEq/L
Creatinine: 1.1 mg/dL

Arrange the following interventions in the most appropriate chronological sequence to safely manage this patient's acute presentation.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequential management of hyperleukocytosis with leukostasis is: Intravenous hydration, followed by rasburicase administration, followed by cytoreduction (leukapheresis), and finally pRBC transfusion.
The correct sequence of management for hyperleukocytosis with clinical leukostasis requires mitigating hyperviscosity and tumor lysis before addressing the profound anemia. Leukostasis occurs when massive numbers of circulating blasts—particularly large, rigid myeloblasts in AML—cause microvascular occlusion, leading to tissue hypoxia (manifesting here as headache, visual changes, retinal hemorrhages, and dyspnea). Intravascular volume expansion with isotonic fluids is the most critical initial step to gently decrease blood viscosity and maintain renal perfusion. Following hydration, pharmacologic prophylaxis for tumor lysis syndrome with a urate oxidase (rasburicase) must be administered immediately, as spontaneous and treatment-induced tumor lysis will severely stress the kidneys. Only after these stabilizing measures should cytoreduction (via leukapheresis or hydroxyurea) be initiated to mechanically or chemically reduce the leukemic burden. Finally, despite the presence of severe symptomatic anemia, packed red blood cell transfusion is strictly contraindicated until the white blood cell count is safely reduced. Premature transfusion increases the fractional volume of cellular elements (hematocrit + leukocrit), exponentially raising whole blood viscosity and frequently precipitating fatal ischemic events.

Step-by-Step Solution

1
Initiate aggressive intravenous hydration with isotonic crystalloids
Intravascular volume expansion and immediate dilution of circulating blood.
Decreases the immediate risk of sludging in the microvasculature and protects renal perfusion ahead of massive cell breakdown.
2
Administer recombinant urate oxidase (rasburicase)
Rapid enzymatic degradation of uric acid to the highly soluble allantoin.
Prevents acute renal failure from urate crystal precipitation, which is critical as both spontaneous and cytoreductive cell lysis will severely exacerbate hyperuricemia.
3
Perform mechanical cytoreduction via leukapheresis
Physical removal of circulating myeloblasts from the peripheral blood.
Definitively addresses the root cause of leukostasis by lowering the leukocrit without adding volume or viscosity.
4
Transfuse irradiated, leukoreduced packed red blood cells (pRBCs)
Improvement of oxygen-carrying capacity and resolution of anemic hypoxia.
Can now be safely performed without precipitating a hyperviscosity crisis, as the circulating white blood cell mass has been sufficiently reduced.

Key Concept

Management sequence for hyperleukocytosis and leukostasis in pediatric Acute Myeloid Leukemia (AML)
Question 15Question →

A 16-month-old boy is brought to the pediatric clinic for a routine well-child evaluation. His mother mentions that he is a picky eater and refuses most solid foods. His diet consists predominantly of 3232 to 4040 ounces (approximately 950950 to 1200 mL1200 \text{ mL}) of whole cow's milk daily, supplemented only by small amounts of crackers. He is active but occasionally appears more fatigued than his siblings did at this age. Vital signs are within normal limits. Physical examination reveals conjunctival pallor but no hepatosplenomegaly or lymphadenopathy. Laboratory studies show:

Hemoglobin: 8.4 g/dL8.4 \text{ g/dL}
Mean corpuscular volume (MCV): 66 fL66 \text{ fL}
Red cell distribution width (RDW): 19%19\% (normal: 11.5%−14.5%11.5\% - 14.5\%)
Reticulocyte count: 1.0%1.0\%

Which of the following is the most likely diagnosis?

Show answer & explanation

Answer: Iron deficiency anemia

Answer

Iron deficiency anemia
The most likely diagnosis for this patient is iron deficiency anemia. The child's presentation of pallor and fatigue, combined with a diet excessively high in cow's milk (greater than 2424 ounces per day) and poor solid food intake, is classic for this condition. Cow's milk is notoriously low in iron, and large quantities can also cause occult intestinal blood loss in toddlers. Furthermore, the laboratory findings of a microcytic anemia (low MCV) with an elevated red cell distribution width (RDW) are highly characteristic of iron deficiency anemia. The high RDW reflects anisocytosis (varying red blood cell sizes) as the iron stores become progressively depleted, which helps distinguish it from other causes of microcytosis such as thalassemia.

Step-by-Step Solution

1
Analyze the patient's dietary history and clinical presentation.
The patient consumes an excessive amount of cow's milk (3232-4040 ounces per day) with minimal solid food intake, presenting with pallor and fatigue.
Excessive cow's milk intake in toddlers is the leading cause of nutritional iron deficiency because cow's milk is poor in iron and can cause occult intestinal bleeding.
2
Evaluate the laboratory values.
Hemoglobin is low (8.4 g/dL8.4 \text{ g/dL}), MCV is low (66 fL66 \text{ fL}), and RDW is elevated (19%19\%).
These parameters confirm a microcytic anemia with varying red blood cell sizes (anisocytosis), which is the hallmark laboratory profile of iron deficiency anemia.
3
Differentiate from other causes of microcytic anemia.
Thalassemia trait is ruled out by the high RDW. Lead poisoning is less likely given the classic dietary history.
Combining the dietary risk factors with the classic CBC findings leads directly to the diagnosis of iron deficiency anemia.

Key Concept

Toddlers who consume excessive amounts of cow's milk (greater than 2424 ounces daily) are at high risk for iron deficiency anemia, which classically presents with a microcytic anemia and an elevated red cell distribution width (RDW).
Question 16Question →

Match each pediatric hematologic or oncologic diagnosis with its most characteristic peripheral blood smear finding.

Click a left item, then click its matching right item

Items

Sickle cell disease (in a school-aged child)
Glucose-6-phosphate dehydrogenase (G6PD) deficiency
Iron deficiency anemia
Acute lymphoblastic leukemia (ALL)

Matches

Show answer & explanation

Answer

Sickle cell disease pairs with Howell-Jolly bodies; G6PD deficiency pairs with Heinz bodies and bite cells; Iron deficiency anemia pairs with Microcytic, hypochromic red blood cells; Acute lymphoblastic leukemia pairs with Lymphoblasts.
Each diagnosis has a classic morphological hallmark on the peripheral blood smear driven by its underlying pathophysiology: autosplenectomy in sickle cell disease (Howell-Jolly bodies), oxidative damage in G6PD deficiency (Heinz and bite cells), reduced hemoglobin synthesis in iron deficiency (microcytic, hypochromic cells), and marrow infiltration by immature cells in ALL (lymphoblasts).

Step-by-Step Solution

1
Identify the underlying pathophysiologic mechanism of each condition.
Sickle cell disease leads to functional asplenia; G6PD deficiency leads to oxidative hemoglobin damage; iron deficiency impairs hemoglobin synthesis; ALL involves bone marrow replacement by malignant progenitor cells.
Understanding the mechanism is essential for predicting the cellular appearance on a blood smear.
2
Correlate the mechanism with the classic peripheral blood smear description.
Asplenia leads to retained nuclear remnants (Howell-Jolly bodies); oxidative damage leads to precipitated hemoglobin and subsequent macrophage clearance (Heinz bodies and bite cells); impaired hemoglobin synthesis yields small, pale cells (microcytic/hypochromic); and malignant progenitors appear as immature blasts (lymphoblasts).
This establishes the correct clinical associations required for diagnosis.

Key Concept

Peripheral blood smear findings in pediatric hematologic conditions
Estimated Time:45s
Question 17Question →

A 20-month-old boy is brought to the pediatric emergency department due to a 7-day history of a brassy cough and a rapid decline in his respiratory status over the past 24 hours. The parents report he has been increasingly restless and absolutely refuses to lie flat, insisting on being held in an upright, leaning-forward position. On presentation, his temperature is 37.5∘C37.5^\circ\text{C} (99.5∘F99.5^\circ\text{F}), heart rate is 158/min158/\text{min}, respiratory rate is 56/min56/\text{min}, and blood pressure is 92/54 mmHg92/54\text{ mmHg}. Oxygen saturation is 90%90\% on a non-rebreather mask. Physical examination reveals prominent cervical lymphadenopathy, facial plethora with distended neck veins, severe suprasternal retractions, and a biphasic stridor. A portable bedside chest radiograph demonstrates a markedly widened superior mediastinum with severe extrinsic compression of the distal trachea, narrowing the airway lumen to approximately 2 mm2\text{ mm}. The child is highly agitated and exhibits worsening work of breathing. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Administer empiric high-dose intravenous corticosteroids

Answer

Administer empiric high-dose intravenous corticosteroids to rapidly reduce tumor burden.
The correct answer is to administer empiric high-dose intravenous corticosteroids. This patient is experiencing a life-threatening airway emergency due to extrinsic compression from a massive anterior mediastinal mass (most commonly a hematologic malignancy such as T-cell acute lymphoblastic leukemia or lymphoblastic lymphoma in this age group). In children, the trachea is highly compressible due to incomplete cartilaginous rings. The standard oncologic rule of obtaining a tissue diagnosis before initiating therapy must be abandoned when respiratory collapse is imminent. Corticosteroids are highly lymphocytotoxic and can drastically reduce tumor volume within hours, relieving the obstruction. Securing the airway with general anesthesia and paralytics is strictly contraindicated, as the loss of spontaneous negative intrathoracic pressure and surrounding muscle tone often leads to complete, irreversible airway obstruction that cannot be stented open by an endotracheal tube.

Step-by-Step Solution

1
Identify the primary clinical syndrome from the physical exam and imaging.
The patient has superior mediastinal syndrome with imminent airway collapse due to a large anterior mediastinal mass.
Recognizing the mechanical nature of the obstruction is crucial to avoiding inappropriate medical or procedural interventions.
2
Determine the unique physiologic vulnerabilities of the pediatric airway in this setting.
The pediatric trachea is highly compressible. Supine positioning or loss of spontaneous negative intrathoracic pressure (via sedation/paralytics) can cause irreversible airway closure.
This physiological understanding contraindicates moving the patient to a CT scanner or performing rapid sequence intubation (RSI) with neuromuscular blockade.
3
Select the optimal emergent intervention to relieve the mechanical obstruction.
Initiate empiric high-dose corticosteroids.
While obtaining a tissue biopsy is standard before treating malignancies, impending cardiovascular or respiratory collapse necessitates immediate empiric therapy to shrink the mass (typically a highly steroid-responsive leukemia or lymphoma).

Key Concept

Management of impending airway obstruction due to an anterior mediastinal mass in pediatric hematologic malignancies.

Alternative Method

If available immediately, emergent localized radiation therapy to the mediastinum is an alternative valid approach to rapidly shrink the tumor burden and relieve the airway obstruction when steroids alone are insufficient.
Estimated Time:1m 30s
Question 18Question →

A 9-year-old boy with a known history of sickle cell anemia is brought to the emergency department by his parents due to fever, cough, and severe chest pain that started yesterday. His temperature is 38.9∘C38.9^\circ\text{C} (102.0∘F102.0^\circ\text{F}), heart rate is 120/min120/\text{min}, blood pressure is 105/65 mmHg105/65\text{ mmHg}, and respiratory rate is 30/min30/\text{min}. Oxygen saturation is 89%89\% on room air. Physical examination reveals crackles and decreased breath sounds in the right lower lung field. A chest radiograph demonstrates a new right lower lobe infiltrate. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Admission to the hospital for supplemental oxygen, pain management, and empiric intravenous antibiotics

Answer

Admission to the hospital for supplemental oxygen, pain management, and empiric intravenous antibiotics
The patient's presentation of fever, chest pain, hypoxemia, and a new pulmonary infiltrate is the classic diagnostic criteria for Acute Chest Syndrome (ACS) in the setting of sickle cell disease. ACS is a medical emergency driven by a combination of infection, fat embolism, and vaso-occlusion in the pulmonary microvasculature. The most appropriate immediate management is hospital admission, correction of hypoxemia with supplemental oxygen, aggressive pain management (which also helps prevent splinting and hypoventilation), and empiric intravenous antibiotics (typically a third-generation cephalosporin and a macrolide) to cover common pathogens like Streptococcus pneumoniae and atypical organisms.

Step-by-Step Solution

1
Identify the primary diagnosis based on the clinical triad in a patient with sickle cell disease.
Fever, chest pain, and a new pulmonary infiltrate on chest X-ray in a sickle cell patient confirm the diagnosis of Acute Chest Syndrome (ACS).
ACS is a leading cause of morbidity and mortality in sickle cell disease and requires immediate clinical recognition.
2
Determine the required treatment protocol for the identified emergency.
Management includes prompt hospitalization, supplemental oxygen to correct hypoxia, aggressive pain control, and broad-spectrum intravenous antibiotics.
Hypoxia and pain exacerbate red blood cell sickling, creating a vicious cycle of vaso-occlusion. Empiric antibiotics are necessary because infection is a major trigger for ACS.

Key Concept

Acute Chest Syndrome requires emergent hospitalization, supportive care (oxygen, pain control), and empiric antibiotics to break the cycle of hypoxia and vaso-occlusion.
Question 19Question →

Evaluate the following clinical profiles of pediatric patients presenting with cytopenias. Assign each patient to the fundamental pathophysiologic mechanism or genetic defect that best explains their constellation of clinical and laboratory findings.

Click a left item, then click its matching right item

Items

An infant at the 4-month well-child visit exhibits profound pallor, a webbed neck, and triphalangeal thumbs. Laboratory analysis demonstrates a severe macrocytic anemia with near-absent reticulocytes, alongside preserved leukocyte and platelet lineages.
A previously healthy toddler develops progressive lethargy one month after an unspecified viral upper respiratory illness. Examination is entirely normal except for conjunctival pallor. Investigations reveal isolated normocytic anemia with profound reticulocytopenia; hemoglobin F levels are normal for age.
A school-aged child with microcephaly, short stature, and widespread café-au-lait macules presents with epistaxis. Skeletal surveys demonstrate hypoplastic radii. Blood work confirms severe pancytopenia with elevated fetal hemoglobin.
A kindergarten student undergoes evaluation for chronic foul-smelling diarrhea and recurrent otitis media. Examination highlights metaphyseal chondrodysplasia. Hematologic testing isolates absolute neutropenia as the primary abnormality.
A male toddler with intractable eczema and a history of recurrent bacterial pneumonia develops scattered petechiae. Peripheral smear highlights significant microthrombocytopenia without schistocytes.

Matches

Show answer & explanation

Answer

The accurate pairings link the infant with macrocytic anemia and triphalangeal thumbs to ribosomal protein mutations (Diamond-Blackfan anemia); the previously healthy toddler with normocytic anemia to acquired immune suppression (Transient erythroblastopenia of childhood); the child with pancytopenia and absent radii to defective DNA cross-link repair (Fanconi anemia); the child with neutropenia and diarrhea to SBDS gene defects (Shwachman-Diamond syndrome); and the toddler with eczema and small platelets to defective actin cytoskeleton reorganization (Wiskott-Aldrich syndrome).
Pediatric cytopenias often present with overlapping hematologic findings but possess distinct molecular etiologies and syndromic physical features. Correctly matching these requires identifying key discriminator variables: Diamond-Blackfan anemia features isolated macrocytic anemia with triphalangeal thumbs (ribosomal protein defect); Transient erythroblastopenia of childhood is an acquired, normocytic post-viral suppression; Fanconi anemia presents with progressive pancytopenia and absent radii (DNA repair defect); Shwachman-Diamond syndrome combines neutropenia with pancreatic insufficiency (SBDS gene/ribosome maturation defect); and Wiskott-Aldrich syndrome causes microthrombocytopenia with eczema (actin cytoskeleton defect).

Step-by-Step Solution

1
Differentiate the pure red cell aplasias based on onset age, red cell volume, and physical exam findings.
The infant with macrocytic anemia and physical anomalies matches congenital Diamond-Blackfan anemia, while the older toddler with isolated normocytic anemia matches acquired Transient erythroblastopenia of childhood.
Accurately separating congenital vs. acquired pure red cell aplasia relies on MCV and the presence of syndromic features.
2
Analyze the clinical profile of the child with pancytopenia, microcephaly, and missing radii.
This combination of multisystem defects and global marrow failure points directly to Fanconi anemia, a DNA repair defect.
Recognizing the unique skeletal signature (absent radii vs. triphalangeal thumbs) prevents confusion with other marrow failure syndromes.
3
Identify the syndrome characterized by neutropenia coupled with gastrointestinal malabsorption.
Exocrine pancreatic insufficiency combined with neutropenia and skeletal dysplasia is the hallmark of Shwachman-Diamond syndrome, an SBDS gene mutation.
Both Shwachman-Diamond and Diamond-Blackfan involve ribosomal dysfunction, but they affect completely different primary cell lines and organ systems.
4
Correlate the distinct triad of eczema, recurrent infections, and isolated tiny platelets.
This matches Wiskott-Aldrich syndrome, caused by a failure of actin cytoskeleton reorganization.
Microthrombocytopenia is highly specific to Wiskott-Aldrich in the context of primary immunodeficiency.

Key Concept

Differential diagnosis and molecular pathophysiology of pediatric bone marrow failure syndromes and cytopenias.
Question 20Question →

A 14-month-old boy is brought to the clinic by his parents because of a swollen and tender right knee that developed yesterday. The patient recently started walking independently. The parents deny any major trauma but note that he frequently bumps into furniture. His temperature is 37.1∘C37.1^\circ\text{C} (98.8∘F98.8^\circ\text{F}), pulse is 110/min110/\text{min}, and respirations are 24/min24/\text{min}. Physical examination reveals a moderately swollen, warm right knee with a limited range of motion due to pain. There are also several large ecchymoses on his shins. Laboratory evaluation shows:

Hemoglobin: 11.8 g/dL11.8 \text{ g/dL}
Platelet count: 310,000/mm3310,000/\text{mm}^3
Prothrombin time (PT): 12 seconds12 \text{ seconds} (Normal: 11−15 seconds11-15 \text{ seconds})
Activated partial thromboplastin time (aPTT): 72 seconds72 \text{ seconds} (Normal: 25−40 seconds25-40 \text{ seconds})

Which of the following is the most likely underlying cause of this patient's clinical presentation?

Show answer & explanation

Answer: Inherited deficiency of a coagulation cascade protein

Answer

The correct answer is an inherited deficiency of a coagulation cascade protein, representing Hemophilia A or B.
The correct answer is an inherited deficiency of a coagulation cascade protein. This patient's presentation is classic for hemophilia (either Hemophilia A, factor VIII deficiency; or Hemophilia B, factor IX deficiency). Hemophilia is an X-linked recessive disorder that frequently becomes symptomatic when an affected infant gains mobility (e.g., crawling or walking). The trauma associated with these normal activities leads to deep tissue bleeding, most classically hemarthrosis (bleeding into the joint spaces), which presents as a warm, swollen, and painful joint. Laboratory evaluation hallmarks include a normal platelet count, a normal prothrombin time (PT), and an isolated prolonged activated partial thromboplastin time (aPTT) reflecting an intrinsic pathway defect.

Step-by-Step Solution

1
Analyze the clinical presentation.
A 14-month-old boy who just started walking presents with deep tissue bleeding (hemarthrosis of the knee, large ecchymoses) after minimal trauma.
This specific timing (onset of mobility) and bleeding pattern (joints/muscles) points heavily toward a coagulation factor deficiency.
2
Evaluate the laboratory values.
The patient has a normal platelet count, a normal PT, and an isolated prolongation of the aPTT.
A normal platelet count rules out thrombocytopenia. A normal PT and prolonged aPTT isolate the defect to the intrinsic coagulation pathway.
3
Synthesize findings to determine the mechanism.
The combination of hemarthrosis in a newly walking male and an isolated prolonged aPTT is classic for Hemophilia A (Factor VIII deficiency) or Hemophilia B (Factor IX deficiency), both of which are inherited coagulation cascade defects.
Matching the clinical syndrome with the specific intrinsic pathway defect solidifies the diagnosis.

Key Concept

Hemophilia typically presents when an affected boy begins walking and experiences minor trauma, leading to deep tissue bleeding (e.g., hemarthrosis). Laboratory evaluation is characterized by an isolated prolonged aPTT with a normal PT and platelet count.
Page 1 / 4Next
Pediatric Hematology and Oncology Practice Questions — USMLE Step 2 CK | Examkin